Revenue, last quarter
$211M
+58% vs same quarter last year
Net income
$2M
+112.4% vs same quarter last year
EPS, diluted
$0.03
+110.7% vs same quarter last year
Operating cash flow
$38.6M
+482.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $507.4M | −$187.7M |
| FY24 | $383.5M | −$146.4M |
| FY23 | $314.7M | −$134.7M |
| FY22 | $282.9M | −$99.2M |
| FY21 | $294M | −$49.6M |
| FY20 | $225M | −$120.3M |
| FY19 | $237M | $15.4M |
| FY18 | $181.3M | −$13M |
| FY17 | $159.3M | −$92K |
| FY16 | $114.4M | $4.5M |
| FY15 | $71.7M | −$37.2M |
| FY14 | $45.6M | −$12.1M |
| FY13 | $20.9M | −$12.6M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 55.7% | −39.3% | −37% |
| FY24 | 75.5% | −31.9% | −38.2% |
| FY23 | 76% | −40.9% | −42.8% |
| FY22 | 75.6% | −29.1% | −35.1% |
| FY21 | 77.3% | −11.2% | −16.9% |
| FY20 | 59.2% | −54.9% | −53.5% |
| FY19 | 83.7% | −21.2% | 6.5% |
| FY18 | 86.2% | −7.2% | −7.1% |
| FY17 | 86.8% | −1.4% | −0.1% |
| FY16 | 85.9% | 3.7% | 4% |
| FY15 | 81.9% | −14.4% | −51.9% |
| FY14 | 75% | −28.9% | −26.6% |
| FY13 | 87.9% | −67.8% | −60.3% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$22.5M |
| FY24 | −$67.6M |
| FY23 | −$78M |
| FY22 | −$63.3M |
| FY21 | −$23.1M |
| FY20 | −$29.9M |
| FY19 | −$5.1M |
| FY18 | $8.5M |
| FY17 | $19.8M |
| FY16 | $6M |
| FY15 | −$3.1M |
| FY14 | −$8M |
| FY13 | −$14.2M |
| FY12 | - |
- Glaukos
- Healthcare median
Show the numbers
| Year | Glaukos | Healthcare median |
|---|---|---|
| FY25 | −37% | −30.6% |
| FY24 | −38.2% | −47% |
| FY23 | −42.8% | −58% |
| FY22 | −35.1% | −80.4% |
| FY21 | −16.9% | −71.9% |
| FY20 | −53.5% | −62.2% |
| FY19 | 6.5% | −46.3% |
| FY18 | −7.1% | −49.6% |
| FY17 | −0.1% | −45.9% |
| FY16 | 4% | −36% |
| FY15 | −51.9% | −38.4% |
| FY14 | −26.6% | −35.5% |
| FY13 | −60.3% | −37.1% |
| FY12 | - | −29.1% |